Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

CD47 expression in gastric cancer clinical correlates and association with macrophage infiltration
Mingsu Shi, Yun Gu, Kaifeng Jin, et al.
Cancer Immunology Immunotherapy (2021) Vol. 70, Iss. 7, pp. 1831-1840
Open Access | Times Cited: 51

Showing 1-25 of 51 citing articles:

Targeting CD47 for cancer immunotherapy
Zhongxing Jiang, Haowei Sun, Jifeng Yu, et al.
Journal of Hematology & Oncology (2021) Vol. 14, Iss. 1
Open Access | Times Cited: 241
Extracellular‐Vesicle‐Based Drug Delivery Systems for Enhanced Antitumor Therapies through Modulating the Cancer‐Immunity Cycle
Tuying Yong, Zhaohan Wei, Lu Gan, et al.
Advanced Materials (2022) Vol. 34, Iss. 52
Closed Access | Times Cited: 82
Advanced insights on tumor-associated macrophages revealed by single-cell RNA sequencing: The intratumor heterogeneity, functional phenotypes, and cellular interactions
Sen Yang, Mengyi Wang, Yuze Hua, et al.
Cancer Letters (2024) Vol. 584, pp. 216610-216610
Closed Access | Times Cited: 9
Antitumor Research Based on Drug Delivery Carriers: Reversing the Polarization of Tumor-Associated Macrophages
Xinyu Cao, Shen Wan, Bingyu Wu, et al.
Molecular Pharmaceutics (2025)
Closed Access | Times Cited: 1
Upregulation of THBS1 is Related to Immunity and Chemotherapy Resistance in Gastric Cancer
Xiuyuan Zhang, Tingting Huang, Yiming Li, et al.
International Journal of General Medicine (2021) Vol. Volume 14, pp. 4945-4957
Open Access | Times Cited: 45
Thrombospondin-2 acts as a bridge between tumor extracellular matrix and immune infiltration in pancreatic and stomach adenocarcinomas: an integrative pan-cancer analysis
Xingchen Liao, Wei Wang, Baoping Yu, et al.
Cancer Cell International (2022) Vol. 22, Iss. 1
Open Access | Times Cited: 29
Design of a novel chimeric peptide via dual blockade of CD47/SIRPα and PD-1/PD-L1 for cancer immunotherapy
Zheng Hu, Wanqiong Li, Shaomeng Chen, et al.
Science China Life Sciences (2023) Vol. 66, Iss. 10, pp. 2310-2328
Closed Access | Times Cited: 22
Tumour‐associated macrophages in gastric cancer: From function and mechanism to application
Jie Li, Juan Sun, Ziyang Zeng, et al.
Clinical and Translational Medicine (2023) Vol. 13, Iss. 8
Open Access | Times Cited: 22
Fatty Acids, CD36, Thrombospondin-1, and CD47 in Glioblastoma: Together and/or Separately?
Cristiana Tănase, Ana‐Maria Enciu, Elena Codrici, et al.
International Journal of Molecular Sciences (2022) Vol. 23, Iss. 2, pp. 604-604
Open Access | Times Cited: 24
ARID1Amutations in cancer development: mechanism and therapy
Xuewei Zhang, Yixuan Zhang, Jinyi Zhao, et al.
Carcinogenesis (2023) Vol. 44, Iss. 3, pp. 197-208
Closed Access | Times Cited: 15
Immunology and immunotherapy in gastric cancer
Xiaqing Xu, Jiaxing Chen, Wenxing Li, et al.
Clinical and Experimental Medicine (2023) Vol. 23, Iss. 7, pp. 3189-3204
Closed Access | Times Cited: 15
Research progress on the immune microenvironment and immunotherapy in gastric cancer
Pei Mou, Qing-hua Ge, Rong Sheng, et al.
Frontiers in Immunology (2023) Vol. 14
Open Access | Times Cited: 15
Potential therapeutic targets in myeloid cell therapy for overcoming chemoresistance and immune suppression in gastrointestinal tumors
Jiawei Fan, Jianshu Zhu, He Zhu, et al.
Critical Reviews in Oncology/Hematology (2024) Vol. 198, pp. 104362-104362
Open Access | Times Cited: 5
BCMA/CD47-directed universal CAR-T cells exhibit excellent antitumor activity in multiple myeloma
Qizhong Lu, Hexian Li, Zhiguo Wu, et al.
Journal of Nanobiotechnology (2024) Vol. 22, Iss. 1
Open Access | Times Cited: 5
Surface‐Engineered Extracellular Vesicles with CDH17 Nanobodies to Efficiently Deliver Imaging Probes and Chemo‐Photothermal Drugs for Gastric Cancer Theragnostic
Peng Xia, Haitao Yuan, Ming Tian, et al.
Advanced Functional Materials (2022) Vol. 33, Iss. 7
Closed Access | Times Cited: 22
Progress in cancer research on the regulator of phagocytosis CD47, which determines the fate of tumor cells (Review)
Fan Wu, Hongyuan Pang, Fan Li, et al.
Oncology Letters (2024) Vol. 27, Iss. 6
Open Access | Times Cited: 4
The tumor immune composition of mismatch repair deficient and Epstein-Barr virus-positive gastric cancer: A systematic review
J. Bos, Tessa S. Groen-van Schooten, C.P. Brugman, et al.
Cancer Treatment Reviews (2024) Vol. 127, pp. 102737-102737
Open Access | Times Cited: 4
Oncolytic vaccinia virus armed with anti-CD47 nanobody elicit potent antitumor effects on multiple tumor models via enhancing innate and adoptive immunity
Zengpeng Li, Mengyuan Li, Yang Liu, et al.
Journal for ImmunoTherapy of Cancer (2024) Vol. 12, Iss. 12, pp. e009473-e009473
Open Access | Times Cited: 3
Synergistic effect of CD47 blockade in combination with cordycepin treatment against cancer
Feng Chen, Rongzhang Chen, Weiwei Fang, et al.
Frontiers in Pharmacology (2023) Vol. 14
Open Access | Times Cited: 9
Genetic engineering strategies to enhance antitumor reactivity and reduce alloreactivity for allogeneic cell-based cancer therapy
Yuning Chen, Yichen Zhu, Adam Kramer, et al.
Frontiers in Medicine (2023) Vol. 10
Open Access | Times Cited: 8
The biological roles of CD47 in ovarian cancer progression
Linan Xing, Zhao Wang, Yue Feng, et al.
Cancer Immunology Immunotherapy (2024) Vol. 73, Iss. 8
Open Access | Times Cited: 2
Immune inactivation by CD47 expression predicts clinical outcomes and therapeutic responses in clear cell renal cell carcinoma patients
Wenbin Jiang, Han Zeng, Zhaopei Liu, et al.
Urologic Oncology Seminars and Original Investigations (2022) Vol. 40, Iss. 4, pp. 166.e15-166.e25
Closed Access | Times Cited: 9
Anti-CD47 Antibody Enhances the Efficacy of Chemotherapy in Patients with Gastric Cancer Liver Metastasis
Zhaorui Liu, Huiying Chen, Na Ta, et al.
Journal of Cancer (2023) Vol. 14, Iss. 3, pp. 350-359
Open Access | Times Cited: 5
ZFP36L1 Promotes Gastric Cancer Progression via Regulating JNK and p38 MAPK Signaling Pathways
Kang Ding, Fengping Zhang, Gaoxiu Qi, et al.
Recent Patents on Anti-Cancer Drug Discovery (2022) Vol. 18, Iss. 1, pp. 80-91
Closed Access | Times Cited: 8
Flavokawain B Weakens Gastric Cancer Progression via the TGF-β1/SMAD4 Pathway and Attenuates M2 Macrophage Polarization
Yongzhao Zhu, Weining Fan, Yuanzhen Wang, et al.
Journal of Immunology Research (2022) Vol. 2022, pp. 1-22
Open Access | Times Cited: 8
Page 1 - Next Page

Scroll to top